National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
December 14, 2010 • Volume 7 / Number 24 Update

NCI Recovery Act Web Site Highlights Research on Genomic Mutations in Childhood Cancers

Opening image from 'Targeting Neuroblastoma' videoNCI TARGET researchers are working to keep 5-year-old Hayley's neuroblastoma in remission through genetic targeting. Recovery Act funds are making it possible. Click on the image above to watch her story.

The NCI Recovery Act Web site has added a new article and video that highlight NCI’s Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative. Through this initiative, researchers aim to identify genetic markers that will lead to new and more effective therapies for childhood cancers.

Supplemental funding through the Recovery Act has expanded the TARGET initiative to include more pediatric cancer types, as well as sustained research on neuroblastoma, a solid tumor that arises in immature nerve cells. The goal of the neuroblastoma project is to find alterations in the neuroblastoma genome that are important to the development of the high-risk form of the disease and, more importantly, which forms of the disease can potentially be treated with targeted therapies.